Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism

IF 3.4 3区 医学 Q1 HEMATOLOGY Thrombosis research Pub Date : 2025-03-01 Epub Date: 2025-01-22 DOI:10.1016/j.thromres.2025.109274
Emilie Sonne-Holm , Jesper Kjærgaard , Lia E. Bang , Lars Køber , Emil Fosbøl , Christian Hassager , Rasmus Paulin Beske , Jørn Carlsen , Matilde Winther-Jensen
{"title":"Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism","authors":"Emilie Sonne-Holm ,&nbsp;Jesper Kjærgaard ,&nbsp;Lia E. Bang ,&nbsp;Lars Køber ,&nbsp;Emil Fosbøl ,&nbsp;Christian Hassager ,&nbsp;Rasmus Paulin Beske ,&nbsp;Jørn Carlsen ,&nbsp;Matilde Winther-Jensen","doi":"10.1016/j.thromres.2025.109274","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In patients with pulmonary embolism (PE), the impact of repeated troponin I or T (TnI/TnT) measurements remains unclear.</div></div><div><h3>Methods</h3><div>Using Danish national registries, we identified PE patients (≥18 years) hospitalized between 2013 and 2018 with initial TnI or TnT measurement within −1/+1 day from admission and &gt;1 repeated measurement within three days. Trajectories of TnI and TnT were identified using latent class trajectory modeling. Hazard ratios for 30-day mortality were compared across trajectories via multivariable Cox regression.</div></div><div><h3>Results</h3><div>Among 1539 patients with TnI measurements and 1323 with TnT measurements, three distinct trajectories were identified. Trajectory I (n<sub>TnI</sub> = 286, n<sub>TnT</sub> = 472) exhibited consistently low TnI/TnT concentrations, trajectory II (n<sub>TnI</sub> = 1076, n<sub>TnT</sub> = 724) demonstrated initial elevated TnI/TnT decreasing within 24 h, and trajectory III (n<sub>TnI</sub> = 177, n<sub>TnT</sub> = 127) was characterized by elevated index TnI/TnT increasing within 10 h. 30-day mortality rates were higher in trajectory II and III compared to I in both the TnI (3 %, 7 % and 18 % across trajectory I to III) and the TnT (1 %, 9 % and 20 % across trajectory I to III) cohort. After adjustment hazard ratio of 30-day mortality for trajectory II vs. I was 7.42 (95 % CI 1.00–54.84, <em>p</em> = 0.04, TnI) and 2.93 (95 % CI 1.17–7.33, <em>p</em> = 0.02 TnT); and for trajectory III vs. I, 16.42 (95 % CI 2.42–127.29, <em>p</em> = 0.007, TnI) and 8.21 (95 % CI 2.78–24.19, <em>p</em> &lt; 0.001, TnT).</div></div><div><h3>Conclusion</h3><div>A steep increase in TnI or TnT concentration within 10 h of PE diagnosis significantly escalates 30-day mortality risk indicating that early serial sampling may enhance risk stratification of PE patients.</div></div>","PeriodicalId":23064,"journal":{"name":"Thrombosis research","volume":"247 ","pages":"Article 109274"},"PeriodicalIF":3.4000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thrombosis research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0049384825000234","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In patients with pulmonary embolism (PE), the impact of repeated troponin I or T (TnI/TnT) measurements remains unclear.

Methods

Using Danish national registries, we identified PE patients (≥18 years) hospitalized between 2013 and 2018 with initial TnI or TnT measurement within −1/+1 day from admission and >1 repeated measurement within three days. Trajectories of TnI and TnT were identified using latent class trajectory modeling. Hazard ratios for 30-day mortality were compared across trajectories via multivariable Cox regression.

Results

Among 1539 patients with TnI measurements and 1323 with TnT measurements, three distinct trajectories were identified. Trajectory I (nTnI = 286, nTnT = 472) exhibited consistently low TnI/TnT concentrations, trajectory II (nTnI = 1076, nTnT = 724) demonstrated initial elevated TnI/TnT decreasing within 24 h, and trajectory III (nTnI = 177, nTnT = 127) was characterized by elevated index TnI/TnT increasing within 10 h. 30-day mortality rates were higher in trajectory II and III compared to I in both the TnI (3 %, 7 % and 18 % across trajectory I to III) and the TnT (1 %, 9 % and 20 % across trajectory I to III) cohort. After adjustment hazard ratio of 30-day mortality for trajectory II vs. I was 7.42 (95 % CI 1.00–54.84, p = 0.04, TnI) and 2.93 (95 % CI 1.17–7.33, p = 0.02 TnT); and for trajectory III vs. I, 16.42 (95 % CI 2.42–127.29, p = 0.007, TnI) and 8.21 (95 % CI 2.78–24.19, p < 0.001, TnT).

Conclusion

A steep increase in TnI or TnT concentration within 10 h of PE diagnosis significantly escalates 30-day mortality risk indicating that early serial sampling may enhance risk stratification of PE patients.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肺栓塞住院患者肌钙蛋白动态变化和30天死亡率。
背景:在肺栓塞(PE)患者中,重复肌钙蛋白I或T (TnI/TnT)测量的影响尚不清楚。方法:使用丹麦国家登记处,我们确定了2013年至2018年期间住院的PE患者(≥18岁),他们在入院后-1/+1天内首次测量TnI或TnT,并在3天内重复测量bbb1。利用潜在类轨迹模型识别TnI和TnT的轨迹。通过多变量Cox回归比较30天死亡率的风险比。结果:在1539例TnI检测患者和1323例TnT检测患者中,确定了三种不同的轨迹。轨迹我(nTnI = 286, nTnT = 472)表现出持续低交通噪音指数/ TnT浓度,轨迹二世(nTnI = 1076, nTnT = 724)演示了初始高架交通噪音指数/ TnT在24 h,减少和轨迹III (nTnI = 177, nTnT = 127)被提升为特征索引TnI / TnT在10 h。增加30天死亡率高的轨迹II和III相比,我在交通噪音指数(3%、7%和18%的轨迹我III)和TnT (1%,在轨迹I到III的队列中分别为9%和20%。调整后,轨迹II与轨迹I的30天死亡率风险比分别为7.42 (95% CI 1.00 ~ 54.84, p = 0.04, TnI)和2.93 (95% CI 1.17 ~ 7.33, p = 0.02 TnT);对于轨迹III和轨迹I,分别为16.42 (95% CI 2.42-127.29, p = 0.007, TnI)和8.21 (95% CI 2.78-24.19, p)。结论:PE诊断后10小时内TnI或TnT浓度的急剧增加显著增加了PE患者30天死亡风险,表明早期连续采样可能增强PE患者的风险分层。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Thrombosis research
Thrombosis research 医学-外周血管病
CiteScore
14.60
自引率
4.00%
发文量
364
审稿时长
31 days
期刊介绍: Thrombosis Research is an international journal dedicated to the swift dissemination of new information on thrombosis, hemostasis, and vascular biology, aimed at advancing both science and clinical care. The journal publishes peer-reviewed original research, reviews, editorials, opinions, and critiques, covering both basic and clinical studies. Priority is given to research that promises novel approaches in the diagnosis, therapy, prognosis, and prevention of thrombotic and hemorrhagic diseases.
期刊最新文献
Safety and efficacy of direct oral anticoagulants in children with infection-related cerebral venous thrombosis: a real-life multicenter retrospective study Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: a systematic review and meta-analysis Single center retrospective comparison of bivalirudin and unfractionated heparin for therapeutic anticoagulation in pediatric patients Thrombosis after surgical splenectomy – why, in whom and can we prevent it? Impact of concurrent antiplatelet use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1